RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Edward C. Bell to Drug Utilization

This is a "connection" page, showing publications Edward C. Bell has written about Drug Utilization.
Connection Strength

0.151
  1. Batton B, Li L, Newman NS, Das A, Watterberg KL, Yoder BA, Faix RG, Laughon MM, Stoll BJ, Van Meurs KP, Carlo WA, Poindexter BB, Bell EF, S?nchez PJ, Ehrenkranz RA, Goldberg RN, Laptook AR, Kennedy KA, Frantz ID, Shankaran S, Schibler K, Higgins RD, Walsh MC. Use of antihypotensive therapies in extremely preterm infants. Pediatrics. 2013 Jun; 131(6):e1865-73.
    View in: PubMed
    Score: 0.113
  2. Travers CP, Carlo WA, McDonald SA, Das A, Bell EF, Ambalavanan N, Jobe AH, Goldberg RN, D'Angio CT, Stoll BJ, Shankaran S, Laptook AR, Schmidt B, Walsh MC, S?nchez PJ, Ball MB, Hale EC, Newman NS, Higgins RD. Mortality and pulmonary outcomes of extremely preterm infants exposed to antenatal corticosteroids. Am J Obstet Gynecol. 2018 01; 218(1):130.e1-130.e13.
    View in: PubMed
    Score: 0.039
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support